Volume 36 Issue 4
Jul.  2020
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2020  >  36(4): 438-443
GUOYin-hua, TONGXing-li, TANYong. Clinical Study of Bushen Cupailuan Decoction in the Treatment of Polycystic Ovarian Syndrome Patients with Kidney Deficiency Symptom in vitro Fertilization-Embryo Transfer[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(4): 438-443.
Citation: GUOYin-hua, TONGXing-li, TANYong. Clinical Study of Bushen Cupailuan Decoction in the Treatment of Polycystic Ovarian Syndrome Patients with Kidney Deficiency Symptom in vitro Fertilization-Embryo Transfer[J]. Journal of Nanjing University of traditional Chinese Medicine, 2020, 36(4): 438-443.
shu

Clinical Study of Bushen Cupailuan Decoction in the Treatment of Polycystic Ovarian Syndrome Patients with Kidney Deficiency Symptom in vitro Fertilization-Embryo Transfer

  • 1.

    The Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210029, China

  • 2.

    The First School of Clinical Medicine, Nanjing University of Chinese Medicine, Nanjing, 210023, China

  • Publish Date: 2020-07-10
    Abstract
  • OBJECTIVE To observe the clinical effect of Bushen Cupailuan decoction on polycystic ovarian syndrome (PCOS) patients with kidney deficiency symptom in vitro fertilization-embryo transfer (IVF-ET). METHODS 50 PCOS patients with kidney deficiency symptom who were given long protocol in luteal phase with IVF-ET were enrolled. They were divided into the treatment group and the control group， with 25 cases each group. The treatment group was given Bushen Cupailuan decoction and life guidance for three cycles， followed by the cycle of long protocol in luteal phase with IVF-ET. The control group was given a three-cycle life guidance before the cycle of long protocol in luteal phase with IVF-ET. The serum anti-mullerian hormone (AMH)， testosterone (T)， luteinizing hormone (LH)， body mass index (BMI)， acne and hirsutism score， and traditional Chinese medicine (TCM) syndrome score in the two groups were observed. After IVF-ET， the number of ovums harvested， total gonadotropin (GN)， GN days， 2PN rate， 2PN cleavage rate， high qualified embryo rate， moderate and severe ovarian hyperstimulation syndrome (OHSS) rate， frozen embryo transfer (FET) clinical pregnancy rate and early miscarriage rate were compared. RESULTS After treatment， as for the treatment group， the levels of serum AMH， T， LH and TCM syndrome score decreased significantly compared with levels before treatment. The acne and hirsutism scores in the treatment group were improved significantly compared with those before treatment. The GN days and total GN were lower than those in the control group. The 2PN rate， cleavage rate， and high qualified embryo rate were higher than those in the control group， which had statitistical differences (P<0.01). The incidence of OHSS was lower than that in the control group. The clinical pregnancy rate of frozen embryo transplantation was higher than that in the control group， and the early miscarriage rate was lower than that in the control group (P<0.05). CONCLUSION In terms of PCOS patients， Bushen Cupailuan decoction can effectively improve the basic endocrine hormones， ovum quality， the embryonic rate and the clinical pregnancy rate. In addition， it can reduce the miscarriage rate， the number of days and total amount of gonadotropins and the incidence of OHSS.

     

    • FullText(HTML)
  • loading
    • References(21)
  • [1]
    崔琳琳，陈子江．多囊卵巢综合征诊断标准和诊疗指南介绍[J]．国际生殖健康/计划生育杂志，2011，30(5)：405-408．
    [2]
    朱文锋．中医诊断学[M]．北京：中国中医药出版社，2002:194-195.
    [3]
    谈勇．中医妇科学[M]．北京：中国中医药出版社，2004:282-287.
    [4]
    Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology． The Istanbul consensus workshop on embryo assessment：Proceedings of an expert meeting[J]．Hum Reprod，2011，26(6)：1270-1283．
    [5]
    LI Y，MA Y，CHEN XH，et al．Different diagnostic power of anti-Mullerian hormone in evaluating women with polycystic ovaries with and without hyperandrogenism[J]． J Assist Reprod Genet，2012，29(10)：1147-1151．
    [6]
    FLUHR JW， DEGITZ K. Antibiotics， azelaic acid and benzoyl peroxide in topical acne therapy[J]. J Dtsch Dermatol Ges，2010，8(S1):S24-S30.
    [7]
    LONG WQ， RANCHIN V， PAUTIER P， et al. Detection of minimal levels of serum anti-müllerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay[J]. J Clin Endocrinol Metab， 2000， 85(2):540-544.
    [8]
    SEIFER DB， MACLAUGHLIN DT， CHRISTIAN BP， et al. Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles[J]. Fertil Steril， 2002， 77(3):468-471.
    [9]
    侯延庆，叶元.血清抗苗勒管激素水平在多囊卵巢综合征的临床意义[J].国际检验医学杂志，2013，34(1):9-10.
    [10]
    MORAN LJ， HARRISON CL， HUTCHISON SK， et al. Exercise decreases anti-Müllerian hormone in anovulatory overweight women with polycystic ovary syndrome: A pilot study[J]. Horm Metab Res，2011， 43(13): 977-979．
    [11]
    CATTEAU-JONARD S， PIGNY P， REYSS AC， et al．Changes in serum antimullerian hormone level during low-dose recombinant follicularstimulating hormone therapy for anovulation in polycystic ovary syndrome[J]. J Clin Endocrinol Metab， 2007， 92(11): 4138-4143．
    [12]
    GRUIJTERS MJ， VISSER JA， DURLINGER AL， et al. Anti-Müllerian hormone and its role in ovarian function[J]. Mol Cell Endocrinol， 2003， 211(1/2): 85-90.
    [13]
    QIAO J， FENG HL. Extra and intraovarian factors in polycystic ovary syndrome: Impact on oocyte maturation and embryo developmental competence [J]. Hum Reprod Update， 2011， 17(1): 17-33.
    [14]
    HAZOUT A， BOUCHARD P， SEIFER DB， et al. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone， inhibin B， or estradiol[J]. Fertil Steril， 2004， 82(5):1323-1329.
    [15]
    郭银华，谈勇，邹奕洁，等．补肾促排卵汤联合枸橼酸氯米芬片治疗多囊卵巢综合征所致不孕症及妊娠结局临床观察[J]．湖北中医药大学学报，2013，15(6)：53-54．
    [16]
    郭银华．补肾促排卵汤对多囊卵巢综合征排卵功能障碍性不孕症干预机制的研究[D]．南京：南京中医药大学，2016．
    [17]
    BHIDE P，GUDI A，SHAH A，et al．Anti-müllerian hormone as a predictor of pregnancy following IVF[J]．Reprod Biomed Online，2013，26(3)：247-252．
    [18]
    李曼，温冬梅，王伟佳，等．AMH、FSH、LH、E2联合检测在不孕症患者卵巢储备功能中的预测价值[J]．检验医学与临床，2017，14(12)：1729-1731．
    [19]
    孙静，熊晓英，齐国华，等．血清抗苗勒管激素水平与多囊卵巢综合征激素特征关系的研究[J]．海南医学，2009，20(6)：21-22，31．
    [20]
    袁利，程明刚，刘香萍，等．深圳地区健康育龄妇女血清中AMH水平现况及其在PCOS和POF诊疗中的价值[J]．现代检验医学杂志，2017，32(5)：141-144．
    [21]
    万启军，张颖，杨悌．多囊卵巢综合征患者抗苗勒氏管激素、睾酮和胰岛素抵抗相关性的临床研究[J]．中国血液流变学杂志，2017，27(3)：320-322．
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (631) PDF downloads(471) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return